Quintessence Theatre Company is located in Philadelphia, PA. The organization was established in 2010. According to its NTEE Classification (A60) the organization is classified as: Performing Arts, under the broad grouping of Arts, Culture & Humanities and related organizations. As of 07/2023, Quintessence Theatre Company employed 56 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Quintessence Theatre Company is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 07/2023, Quintessence Theatre Company generated $1.8m in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 17.0% each year . All expenses for the organization totaled $1.7m during the year ending 07/2023. While expenses have increased by 16.2% per year over the past 4 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
DEDICATED TO THE PERFORMANCE AND ADAPTATION OF EPIC WORKS OF CLASSIC LITERATURE AND DRAMA.
Describe the Organization's Program Activity:
Part 3 - Line 4a
QUINTESSENCE THEATRE CONTINUED TO PRODUCE LIVE AND IN-PERSON DURING OUR SEASON XIII: CELEBRATING THE EXTRAORDINARY, WITH VIRTUAL STREAMING OPTIONS AVAILABLE FOR SELECT PRODUCTIONS. EACH PRODUCTION WAS CHOSEN TO REMIND OUR AUDIENCES AND CITY AT LARGE OF THE INCREDIBLE POWER OF THEATRE, AND THE THEATRICAL IMAGINATION. MANY ARE ASKING "WHY" SHOULD THEATRE STILL EXIST IN THE AGE OF STREAMING CONTENT, AND EACH PIECE WAS CHOSEN BECAUSE IN ITS OWN TIME IT PUSHED THE LIMITS OF OUR ART FORM, AND CONTINUES TO PUT WHAT MAKES THEATRE ESSENTIAL AND EXCEPTIONAL FRONT AND CENTER. STARTING WITH THE ABSURD GENIUS OF EUGNE IONESCO'S THE CHAIRS PERFORMED BY TWO OF PHILADELPHIA'S FINEST VETERAN ARTISTS (FRANK X AND E. ASHLEY IZARD), FOLLOWED BY OUR BARE STAGE,ACTOR AND CHALK DRIVEN, BUT PURE MAGIC PRODUCTION OF [CONT ON SCH O]MARY POPPINS (HANNA GAFFNEY WON THE 2023 BARRYMORE AWARD FOR BEST ACTOR IN A MUSICAL FOR HER PORTRAYAL OF THE INFAMOUS NANNY), TO THE EVOCATIVE AND PRESCIENT AMERICAN LABOR CLASSIC WAITING FOR LEFTY, WHICH OPENED WHILE A STRIKE WAS TAKING PLACE AT AN AMAZON WAREHOUSE ONLY MILES AWAY, TO CELEBRATED TV AND STAGE ACTOR LAWRENCE PRESSMAN'S RETURN TO QUINTESSENCE (AWAKE AND SING!) TO MAKE HIS SWAN SONG AS PROSPERO IN THE TEMPEST. AND OUR SEASON FINALE, AND FIRST COMMISSIONED WORLD PREMIERE PLAY, WRITTEN BY PHILLIS, UNLEASHING THE SUBLIME VERSE OF ONE OF AMERICA'S GREATEST POETS ON OUR STAGE. OUR INAUGURAL GET LIT GATHERING LAUNCHED IN THE SUMMER OF 2022 WITH THE CREATION OF WRITTEN BY PHILLIS. QUINTESSENCE RECEIVED ITS FIRST GRANTS FOR ARTS PROJECTS AWARD FROM THE NAT'L ENDOWMENT FOR THE ARTS FOR WRITTEN BY PHILLIS, AND SPECIFICALLY TO SUPPORT THE COMMISSIONING FEES FOR PLAYWRIGHTS PAUL OAKLEY STOVALL AND MARILYN CAMPBELL-LOWE, AS WELL AS HOUSING FOR THE DIRECTOR, CHICAGO'S CHERYL LYNN BRUCE. CONCEIVED AND CREATED AS PART OF QUINTESSENCE'S COLLABORATION WITH CHICAGO'S NEW CLASSICS COLLECTIVE, THIS ORIGINAL PLAY BASED ON THE LIFE OF PHILLIS WHEATLEY (AN ENSLAVED WOMAN AND THE FIRST AFRICAN AMERICAN AND SECOND FEMALE TO HAVE A BOOK OF POETRY PUBLISHED IN THE U.S.) PUTS WHEATLEY'S POETRY FRONT AND CENTER, RECONSIDERS HER IMPORTANT ROLE IN AMERICA'S FOUNDING AND IDEALS, AND CELEBRATES HER LIFE AND LEGACY. THE NEW PLAY DEVELOPMENT COMPRISED A SERIES OF WORKSHOPS AND READINGS IN 2021-2022, INCLUDING A PUBLIC READING AND DISCUSSION TO ENGAGE LOCAL ARTISTS, SCHOLARS, AND EVERYDAY RESIDENTS' INPUT ON THE PLAY DEVELOPMENT. QUINTESSENCE PRODUCED THE WORLD PREMIERE OF WRITTEN BY PHILLIS IN MAY-JUNE 2023. WRITTEN BY PHILLIS SPARKED A CITY-WIDE CELEBRATION OF A REMARKABLE AFRICAN AMERICAN WOMAN AND POET, OF WHICH OUR PROJECT WAS ONE CENTERPIECE. MANY PATRONS SHARED HOW THEY WERE MOVED BY THE NUANCES OF WHEATLEY'S POETRY AND OVERWHELMED AT LEARNING A MORE COMPLEX NARRATIVE OF HER LIFE. EVEN ON NIGHTS WITHOUT A POST-SHOW CONVERSATION, PATRONS WOULDN'T LEAVE THEY STAYED IN THEIR SEATS AND TALKED, COMPELLED TO DIALOGUE ABOUT THE EXPERIENCE. FURTHER WORKSHOPS AND A SECOND PRODUCTION OF WRITTEN BY PHILLIS ARE PLANNED AT THE CHICAGO SHAKESPEARE THEATER FOR 2025. OVERALL, PRODUCTIONS LAST SEASON PROCEEDED FLUIDLY AND OUR INCREASED MARKETING TO STIMULATE POST-COVID ATTENDANCE PAID OFF. QUINTESSENCE ATTRACTED 12,405 THEATREGOERS, ABOUT 11% BELOW PRE-PANDEMIC LEVELS. THIS RE-GROWTH WAS ATTRIBUTED IN PART TO THE SUCCESS OF OUR HOLIDAY CLASSIC, MARY POPPINS, WHICH GARNERED OUR FIRST SOLD OUT PERFORMANCES POST-PANDEMIC, AND BECAME THE BEST-ATTENDED SHOW IN QUINTESSENCE THEATRE'S 13-YEAR HISTORY. HOWEVER, THERE REMAINED ALMOST NO COVID RELIEF FUNDING FOR THE ARTS IN 2022-2023, AND ENSURING FINANCIAL STABILITY CONTINUED TO BE CHALLENGING IN THE WAKE OF THE PANDEMIC. ONE RELIEF FUNDING STREAM WAS MADE AVAILABLE THROUGH THE STATE OF PA IN FEBRUARY 2023; HOWEVER, ANTICIPATING AND ELIGIBLE FOR $380,000, QUINTESSENCE WAS AWARDED ONLY $37,000 AND STILL AWAITS RECEIPT OF SAID FUNDS. DESPITE THE CHALLENGES THAT HAVE ARISEN, QUINTESSENCE THEATRE REMAINS FIRMLY COMMITTED TO THE PHILADELPHIA COMMUNITY AND ITS ACTORS, ARTISTS, ADMINISTRATORS, AND EDUCATORS. WE ARE FULFILLING OUR MISSION OF BRINGING EPIC WORKS OF CLASSIC DRAMA AND LITERATURE TO THE CONTEMPORARY STAGE IN AN INCREASINGLY INCLUSIVE AND EQUITABLE MANNER, INCLUDING BY REPRESENTING DIVERSE STORIES AND STORYTELLERS ON OUR STAGE. WE ARE IN THE PROCESS OF PURCHASING THE SEDGWICK, EXERCISING OUR OPTION ON DECEMBER 28,2023; OPTION WAS EXTENDED ON MARCH 28,2024. NO DEFINITIVE SETTLEMENT DATE HAS BEEN SCHEDULED BUT HOPE TO ACCOMPLISH THIS BY THE END OF JUNE 2024. WE HAVE A RENOVATION PLAN DEVELOPED BY OUR ARCHITECTS, VOITH & MACAVISH AND GG&A CONSULTANTS. OUR CAPITAL CAMPAIGN FOR QUINTESSENCE AT THE SEDGWICK THEATRE PROVIDED FUNDS FOR ADDRESSING MINOR IMPROVEMENTS, WITH THE LARGER VENUE RENOVATIONS BEGINNING WITH A NEW MARQUEE AND FACADE IMPROVEMENT TO OCCUR IN 2024/2025.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Grace Grillet Interim Ed (eff 10/22) | OfficerTrustee | 40 | $10,000 |
Patricia Stranahan Chair | OfficerTrustee | 1 | $0 |
Daniel Ross Vice Chair | OfficerTrustee | 1 | $0 |
William Wheelan Treasurer | OfficerTrustee | 1 | $0 |
Janice Bogen Secretary | OfficerTrustee | 1 | $0 |
Marilou Buffum Member | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $62,546 |
All other contributions, gifts, grants, and similar amounts not included above | $1,328,347 |
Noncash contributions included in lines 1a–1f | $10,288 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,390,893 |
Total Program Service Revenue | $384,287 |
Investment income | $181 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,782,398 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $60,000 |
Compensation of current officers, directors, key employees. | $8,731 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $772,967 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $84,492 |
Payroll taxes | $58,917 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $134,514 |
Advertising and promotion | $82,811 |
Office expenses | $36,287 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $129,528 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $30,490 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $29,433 |
Insurance | $27,558 |
All other expenses | $0 |
Total functional expenses | $1,672,816 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $126,655 |
Savings and temporary cash investments | $53,278 |
Pledges and grants receivable | $750,624 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $17,476 |
Net Land, buildings, and equipment | $661,225 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $2,248,052 |
Total assets | $3,857,310 |
Accounts payable and accrued expenses | $84,590 |
Grants payable | $0 |
Deferred revenue | $59,106 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $500,000 |
Other liabilities | $2,248,052 |
Total liabilities | $2,891,748 |
Net assets without donor restrictions | -$273,193 |
Net assets with donor restrictions | $1,238,755 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $3,857,310 |